Monique Spillman

Sourced from institutional research profiles (UAMS TRI or ARA).

Professor

UAMS

COM | Obstetrics & Gynecology

26 h-index 152 pubs 3,324 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Monique Spillman, Professor in Obstetrics & Gynecology at the University of Arkansas for Medical Sciences, leads a research group focused on cancer-related molecular mechanisms. Her work has investigated gene expression regulation in neoplastic cells, particularly in the context of ovarian and breast cancers. Spillman has explored the roles of specific proteins and genetic alterations, including studies on the BRCA1 gene product and its interactions, as well as the impact of estrogen on BRCA1 and BRCA2 mRNA levels in breast cancer cells.

Her research also delves into the characterization of cell line models for cancer research. Publications include the identification of misidentification and redundancy in endometrial and ovarian cell lines, and the development of type-specific cell line models for ovarian cancer. Spillman has also examined epigenetic alterations in epithelial ovarian cancer, specifically focusing on the IGF2/H19 domain and IGF2 expression. Further investigations include the regulatory functions of microRNAs and tRNA fragments in ovarian cancer proliferation and sensitivity to chemotherapy.

With an h-index of 26 and over 3,300 citations across 152 publications, Spillman's scholarship metrics reflect a sustained contribution to the field. She has been recently active in research, with her most recent publication in 2026.

Metrics

h-index: 26
Publications: 152
Citations: 3,324

Positions

Professor

University of Arkansas for Medical Sciences COM | Obstetrics & Gynecology Institutional directory
Professor, Division Chief

University of Arkansas for Medical Sciences Obstetrics and Gynecology, Gynecologic Oncology ORCID

Selected Publications

Comparison of cost of endometrial cancer staging between robotic and vNOTES techniques (2026)

Gynecologic Oncology DOI OpenAlex
A pilot study utilizing hypothermia to reduce chemotherapy-induced peripheral neuropathy (2026)

Gynecologic Oncology DOI OpenAlex
Abstract 2589: Prospective verification of OvaPrint and multi-omic profiling for precise adnexal mass classification (2026)

Cancer Research DOI OpenAlex
Polypoid endometriosis with endometrioid intraepithelial neoplasia mimicking malignancy: a rare case of a postmenopausal pelvic mass (2026)

Baylor University Medical Center Proceedings DOI OpenAlex
Uterus Transplant (2024)

JAMA DOI OpenAlex
Sentinel lymph node biopsy for early stage vulvar squamous cell carcinoma (2024)

Baylor University Medical Center Proceedings DOI OpenAlex
Abstract B040: OvaPrintTM – a novel cfDNA methylation liquid biopsy for cancer risk assessment in epithelial ovarian cancer (2024)

Cancer Research DOI OpenAlex
Sentinel Lymph Node Biopsy for Early Stage Vulvar Squamous Cell Carcinoma (2024)

Research Square DOI OpenAlex
OvaPrint—A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer (2023)

Clinical Cancer Research 28 citations DOI OpenAlex
OvaPrint™ – a cell-free DNA methylation liquid biopsy for the risk assessment of high-grade serous ovarian cancer (2023)

Zenodo (CERN European Organization for Nuclear Research) DOI OpenAlex